Benlysta and Ivermectin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Benlysta (belimumab) and Ivermectin (ivermectin). Common drug interactions include influenza among females.

The phase IV clinical study analyzes what interactions people have when they take Benlysta and Ivermectin. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Benlysta?

Benlysta has active ingredients of belimumab. It is often used in systemic lupus erythematosus. eHealthMe is studying from 23,528 Benlysta users. Check the latest studies of Benlysta.

What is Ivermectin?

Ivermectin has active ingredients of ivermectin. eHealthMe is studying from 2,199 Ivermectin users. Check the latest studies of Ivermectin.



On Jul, 06, 2026

15 people who take Benlysta and Ivermectin together, and have interactions are studied.

Benlysta and Ivermectin drug interactions.

What are the common drug interactions of Benlysta and Ivermectin, by gender? *:

female:

  1. Influenza
  2. Weight decreased
  3. Anosmia (partial or complete loss of the sense of smell)
  4. Back pain
  5. Cough
  6. Depression
  7. Disease recurrence
  8. Ill-defined disorder
  9. Infection
  10. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)

male:

n/a

What are the common drug interactions of Benlysta and Ivermectin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anosmia (partial or complete loss of the sense of smell)
  2. Back pain
  3. Cough
  4. Depression
  5. Disease recurrence
  6. Ill-defined disorder
  7. Infection
  8. Influenza
  9. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  10. Nasopharyngitis (inflammation of the nasopharynx)

40-49:

  1. Hospitalisation
  2. Influenza
  3. Limb injury
  4. Skin infection
  5. Skin ulcer
  6. Social problem
  7. Weight decreased
  8. Wound

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Migraine (headache): 5 people, 33.33%
  2. High Blood Pressure: 5 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Benlysta and Ivermectin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Benlysta and Ivermectin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Benlysta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ivermectin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Benlysta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ivermectin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on belimumab and ivermectin (the active ingredients of Benlysta and Ivermectin, respectively), and Benlysta and Ivermectin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: